ZBZimmer Biomet ZBH · NYSE
$94.97 +0.63% (+$0.59)
- Market cap
- $18.2B
- Enterprise value
- $25.3B
- P/E
- 22.6x
- Forward P/E
- 10.8x
- PEG
- -
- P/S
- 2.1x
- P/FCF
- 10.0x
- EV/EBITDA
- 12.9x
- ROIC
- 5.5%
- Gross margin
- 69.9%
- Net margin
- 9.5%
- Dividend yield
- 1.02%
- Payout ratio
- 23.0%
- Net debt/EBITDA
- 3.6x
- Beta
- 0.49
- Free float
- 99.8%
About the company
Zimmer Biomet Holdings, Inc. (ZBH) is an American company specializing in the manufacturing and distribution of medical devices and implants for orthopedics, traumatology, and other medical fields. The company provides a wide range of products, including artificial joints, bone implants, surgical instruments, and bioresorbable materials for the treatment of patients with orthopedic issues. Zimmer Biomet is a respected leader in the healthcare technology industry and contributes to advancements in treatment procedures and patient care. The company collaborates with medical professionals and research institutions to ensure the highest quality and safety of its products. Zimmer Biomet focuses on innovation and the development of new technologies that bring better outcomes and longer implant lifespan for doctors and patients. Its products are sought after and utilized in healthcare facilities worldwide. Shares of Zimmer Biomet Holdings, Inc. (ZBH) could represent an intriguing investment opportunity for those who believe in the growing demand for orthopedic medical devices and the benefits of modern healthcare technologies.
Sector
Healthcare
Industry
Medical - Devices
CEO
Ivan Tornos
Employees
17,000
Headquarters
Warsaw
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number